Ipsen

  • Français
Symbol Last Change
IPN.PA 27.10 € (-0.39 % )
powered by Euronext©
  • The Group
    • Profile & Key figures
      • Message from the Chairman
      • Group history
    • R & D
      • R & D Homepage
      • Neurology
      • Endocrinology
      • Uro-Oncology
    • Medicines
    • Governance
      • Board of directors
      • Board committees
      • Leadership
      • Compensation of corporate officers
    • Business Development & Alliance Management
    • Ipsen worldwide
  • Targeted diseases
    • Neurology
    • Endocrinology
    • Uro-oncology
    • Primary care
  • Commitments
    • Vision, mission and action principles
    • Environment, health and safety
    • Ethics and compliance
    • Support to Patient Organizations
    • Corporate Citizenship
  • Fondation IPSEN
    • La Fondation Ipsen at a glance
    • Colloques, prizes, publications
      • Neurosciences
      • Alzheimer’s disease
      • Endocrinology
      • Cancer science
      • Longevity
      • Vascular
    • Partnerships
      • Salk Institute - Nature
      • Cell Press - DMM Global Foundation
      • Nature Publishing Group
Home > Site Map

Front page

    • All news

Go to

  • Press room
    • Press releases
    • Publications
  • Investor relations
    • Ipsen shares
    • ADR Program
    • Financial calendar
    • Financial results
    • Conferences & Roadshows
    • General meeting
    • Regulated information
    • Other Information
  • Careers
    • Candidate homepage
      • Job offers
    • HR News
    • Mission & Values
    • Key figures

Main Menu

  • The Group
    • Profile & Key figures
      • Message from the Chairman
      • Group history
    • R & D
      • R & D Homepage
      • Neurology
      • Endocrinology
      • Uro-Oncology
    • Medicines
    • Governance
      • Board of directors
      • Board committees
      • Leadership
      • Compensation of corporate officers
    • Business Development & Alliance Management
    • Ipsen worldwide
  • Targeted diseases
    • Neurology
    • Endocrinology
    • Uro-oncology
    • Primary care
  • Commitments
    • Vision, mission and action principles
    • Environment, health and safety
    • Ethics and compliance
    • Support to Patient Organizations
    • Corporate Citizenship
  • Fondation IPSEN
    • La Fondation Ipsen at a glance
    • Colloques, prizes, publications
      • Neurosciences
      • Alzheimer’s disease
      • Endocrinology
      • Cancer science
      • Longevity
      • Vascular
    • Partnerships
      • Salk Institute - Nature
      • Cell Press - DMM Global Foundation
      • Nature Publishing Group

Go to

  • Press room
  • Investor relations
  • Careers
© Ipsen 2010
  • Legal disclaimer
  • Site Map
  • Contact
  • Email alert
  • RSS
  • Ipsen worldwide
  • IPSEN related sites

Ipsen Group website.